Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026

Bulletin Express

May 07

Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.

The company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.

Directors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).

All statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1164039227"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164039227\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164039227?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164039227","market":"us","top_or_hot":-1,"title":"Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026","media":"Bulletin Express","content":"<p>Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.</p>\n<p>The company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.</p>\n<p>Directors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).</p>\n<p>All statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-07 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.</p>\n<p>The company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.</p>\n<p>Directors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).</p>\n<p>All statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06955","symbol_name":"博安生物","start_time":0,"source_url":"","article_id":"1164039227","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164039227","pubTimestamp":1778143492,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06955":"博安生物"},"translate_title":"博安生物维持6.2233亿股已发行股份，并于2026年4月满足公众持股量要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06955":1},"content_text":"Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.\nThe company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.\nDirectors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).\nAll statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}